Related Experiment Video
Updated: Feb 12, 2026
Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
Published on: August 29, 2016
Targeted Hepatic Methylation-Controlled J Protein Inhibition Mitigates Postsurgical Liver Injury and
Kenneth Meza Monge1, Akshay Pratap1, Kevin M Najarro1
1Division of GI, Trauma and Endocrine Surgery, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Background:
Advanced age significantly increases postoperative complication risk, including neurological dysfunction. While the liver plays a critical role in surgical recovery, age-related changes in hepatic function remain inadequately studied in perioperative risk assessment. Methylation-Controlled J protein (MCJ), an endogenous negative regulator of mitochondrial function, represents a promising therapeutic target due to its role in exacerbating oxidative stress and compromising metabolic resilience in aging.
Methods:
Young (4-5 months) and aged (24 months), male and female C57BL/6J mice underwent 60-minute laparotomy surgery or a sham procedure. Treatment groups received hepatocyte-targeted GalNAc-siMCJ (10 mg/kg, subcutaneous) 72 hours before surgery based on established knockdown kinetics. Subclinical liver injury (plasma/tissue cytokeratin-18 and microRNA-122), metabolic dysfunction (kynurenine pathway metabolites), blood-brain barrier integrity [cerebrospinal fluid/plasma albumin ratio and calcium-binding protein S100B], neuroinflammation [glial fibrillary acidic protein and ionized calcium binding adaptor molecule 1 (Iba1)], and cognitive function (open field and novel object recognition) were assessed 48 hours postsurgery.
Results:
Despite normal transaminases (alanine aminotransferase <46 IU/L, aspartate aminotransferase <69 IU/L), livers from aged mice exhibited significant subclinical injury after surgery, with elevated cytokeratin-18 and microRNA-122 ( P < 0.05 vs. aged-sham). This resulted in increased hepatic kynurenine and quinolinic acid ( P < 0.05), blood-brain barrier disruption (increased S100B plasma levels and cerebrospinal fluid/plasma albumin ratio), neuroinflammation (elevated Iba1 immunoreactivity in hippocampus), and cognitive impairment. Hepatic MCJ silencing prevented these alterations in aged mice ( P < 0.05 vs. aged vehicle), without affecting young mice beyond reducing inflammatory markers.
Conclusions:
Targeted hepatic MCJ inhibition mitigates subclinical liver injury, dysregulated kynurenine metabolism, and subsequent neuroinflammation in aged mice after surgery. This liver-brain axis modulation represents a potential therapeutic strategy to prevent perioperative neurological complications in vulnerable older surgical patients.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:09Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
00:46Feedback Inhibition
01:27Post-translational Translocation of Proteins to the RER
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
01:26Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
02:04Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....